PAPER De Schaepdryver M, Goossens J, De Meyer S, Jeromin A, Masrori P, Brix B, Claeys KG, Schaeverbeke J, Adamczuk K, Vandenberghe R, Van Damme P, Poesen K

Serum neurofilament heavy chains as early marker of motor neuron degeneration.

Ann Clin Transl Neurol. 2019 Sep 13; PubMed: 31518073

PAPER Díaz JL, Mondragón H, Sancho J, Aguilar EJ, Servera E

Relationship Between Cognitive-Behavioral Impairment and Clinical and Functional Parameters in ALS and Reliability of the Edinburgh Cognitive and Behavioural ALS Screen to Assess ALS: Preliminary Findings.

Cogn Behav Neurol. 2019 Sep;32(3):185-192. PubMed: 31517702

PAPER Yang Y, Klionsky DJ

A novel role of UBQLNs (ubiquilins) in regulating autophagy, MTOR signaling and v-ATPase function.

Autophagy. 2019 Sep 13;:1-2. PubMed: 31516068

PAPER Vandoorne T, Veys K, Guo W, Sicart A, Vints K, Swijsen A, Moisse M, Eelen G, Gounko NV, Fumagalli L, Fazal R, Germeys C, Quaegebeur A, Fendt SM, Carmeliet P, Verfaillie C, Van Damme P, Ghesquière B, De Bock K, Van Den Bosch L

Differentiation but not ALS mutations in FUS rewires motor neuron metabolism.

Nat Commun. 2019 Sep 12;10(1):4147. PubMed: 31515480

PAPER Gregory JM, McDade K, Bak TH, Pal S, Chandran S, Smith C, Abrahams S

Executive, language and fluency dysfunction are markers of localised TDP-43 cerebral pathology in non-demented ALS.

J Neurol Neurosurg Psychiatry. 2019 Sep 12; PubMed: 31515300

PAPER Bohlen CJ, Friedman BA, Dejanovic B, Sheng M

Microglia in Brain Development, Homeostasis, and Neurodegeneration.

Annu Rev Genet. 2019 Sep 13; PubMed: 31518519

PAPER Groppell S, Soto-Ruiz KM, Flores B, Dawkins W, Smith I, Eagleman DM, Katz Y

A Rapid, Mobile Neurocognitive Screening Test to Aid in Identifying Cognitive Impairment and Dementia (BrainCheck): Cohort Study.

JMIR Aging. 2019 Mar 21;2(1):e12615. PubMed: 31518280

PAPER Mullins RJ, Mustapic M, Chia CW, Carlson O, Gulyani S, Tran J, Li Y, Mattson MP, Resnick S, Egan JM, Greig NH, Kapogiannis D

A pilot study of exenatide actions in Alzheimer's disease.

Curr Alzheimer Res. 2019 Sep 13; PubMed: 31518224

PAPER Park E, Yun BJ, Min YS, Lee YS, Moon SJ, Huh JW, Cha H, Chang Y, Jung TD

Effects of a Mixed Reality-based Cognitive Training System Compared to a Conventional Computer-assisted Cognitive Training System on Mild Cognitive Impairment: A Pilot Study.

Cogn Behav Neurol. 2019 Sep;32(3):172-178. PubMed: 31517700

PAPER Rhodus EK, Barber J, Abner EL, Duff DM, Bardach SH, Caban-Holt A, Lightner D, Rowles GD, Schmitt FA, Jicha GA

Behaviors Characteristic of Autism Spectrum Disorder in a Geriatric Cohort With Mild Cognitive Impairment or Early Dementia.

Alzheimer Dis Assoc Disord. 2019 Sep 11; PubMed: 31517641

PAPER Padova A, Rokytova I, Mravec B, Kvetnansky R, Vargovic P

Exposure to a single immobilization or lipopolysaccharide challenge increases expression of genes implicated in the development of Alzheimer's disease in the mice brain cortex.

Endocr Regul. 2019 Apr 1;53(2):100-109. PubMed: 31517627

PAPER Lee HE, Lim D, Lee JY, Lim SM, Pae AN

Recent tau-targeted clinical strategies for the treatment of Alzheimer's disease.

Future Med Chem. 2019 Aug;11(15):1845-1848. PubMed: 31517533

PAPER Li C, Briner A, Götz J

The search for improved animal models of Alzheimer's disease and novel strategies for therapeutic intervention.

Future Med Chem. 2019 Aug;11(15):1853-1857. PubMed: 31517531

PAPER Adeniyi AA, Conradie J

Computational insight into the anticholinesterase activities and electronic properties of physostigmine analogs.

Future Med Chem. 2019 Aug;11(15):1907-1928. PubMed: 31517530

PAPER Wang G, Aschenbrenner AJ, Li Y, McDade E, Liu L, Benzinger TL, Bateman RJ, Morris JC, Hassenstab JJ, Xiong C

Two-period linear mixed effects models to analyze clinical trials with run-in data when the primary outcome is continuous: Applications to Alzheimer's disease.

Alzheimers Dement (N Y). 2019;5:450-457. Epub 2019 Sep 5 PubMed: 31517032